| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/12/1996 | WO1996027799A1 Method for the diagnosis of infections |
| 09/12/1996 | WO1996027666A1 Novel avian cytokines and genetic sequences encoding same |
| 09/12/1996 | WO1996027665A2 Neuron-restrictive silencer factor proteins |
| 09/12/1996 | WO1996027664A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 09/12/1996 | WO1996027613A1 Mono- and polyclonal antibodies against e2 protein region 63-75 |
| 09/12/1996 | WO1996027612A1 Production in yeasts of stable antibody fragments |
| 09/12/1996 | WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/12/1996 | WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/12/1996 | WO1996027390A1 Compositions and methods for stimulating antibody class switching |
| 09/12/1996 | WO1996027389A1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
| 09/12/1996 | WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 09/12/1996 | WO1996021028A3 Soluble heterodimeric t cell receptors and their antibodies |
| 09/12/1996 | WO1996021016A3 New staphylokinase derivatives |
| 09/12/1996 | WO1996020718A3 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 09/12/1996 | WO1996003502A3 Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer |
| 09/12/1996 | DE19515514C1 DNA encoding nucleolar-endosomal auto-antigen |
| 09/12/1996 | DE19508087A1 Use of anti-histidine antibodies in immunoassays |
| 09/12/1996 | CA2214726A1 Compositions and methods for stimulating antibody class switching |
| 09/12/1996 | CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 09/12/1996 | CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/12/1996 | CA2214453A1 Novel avian cytokines and genetic sequences encoding same |
| 09/12/1996 | CA2214271A1 Neuron-restrictive silencer factor proteins |
| 09/11/1996 | EP0731167A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 09/11/1996 | EP0731166A2 Novel calcium-binding proteins |
| 09/11/1996 | EP0731165A2 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160 |
| 09/11/1996 | EP0730740A1 Kinase receptor activation assay |
| 09/11/1996 | EP0730650A1 Retroviral superantigens, superantigen peptides, and methods of use |
| 09/11/1996 | EP0730649A1 Mutated hig-e fragments and derivative thereof |
| 09/11/1996 | EP0730647A1 Dna sequence coding for a bmp receptor |
| 09/11/1996 | EP0730646A1 PROTEIN TYROSINE KINASES NAMED Rse |
| 09/11/1996 | EP0730643A1 Transgenic animals harboring app allele having swedish mutation |
| 09/11/1996 | EP0730609A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 09/11/1996 | EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 09/11/1996 | EP0534944B1 Antibodies specific for elam-1 and the use thereof |
| 09/11/1996 | EP0484401B1 Production of vascular endothelial cell growth factor |
| 09/11/1996 | EP0372031B1 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 09/11/1996 | EP0339086B1 Electrochemiluminescent rhenium moieties and methods |
| 09/10/1996 | US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 09/10/1996 | US5554542 Immunoassay for isothiazolones |
| 09/10/1996 | US5554538 DNA sequences derived from papillomavirus HPV-33 genome |
| 09/10/1996 | US5554525 Chicken anemia virus vaccine and diagnostic |
| 09/10/1996 | US5554524 More complex type retroviruses having mixed type LTR, and uses thereof |
| 09/10/1996 | US5554515 Immunizing a non-human warm blooded animal with purifiedantigen; recovering an antibody producing cell; fusion of this cell to produce hybrid |
| 09/10/1996 | US5554512 Isolated dna sequence encoding flt3 ligand polypeptide; expression vector comprising the sequence; host cell transformed or transfected with the vector; culture process for producing flt3-l polypeptide; nucleic acid sequences |
| 09/10/1996 | US5554506 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 09/10/1996 | US5554371 Contains antigenic recombinant polypeptide with amino acid sequence corresponding to that of recombinant polypeptide produced by e. coli transformant atcc 68825; immunization process |
| 09/08/1996 | CA2171144A1 Human t-cell line infected with hiv-2 which secretes functionally intact hiv-2 gp160 |
| 09/06/1996 | WO1996027019A1 Transgenic animals as model of psoriasis |
| 09/06/1996 | WO1996027013A1 Group o hiv-1, fragments of such viruses, and uses thereof |
| 09/06/1996 | WO1996027011A1 A method for making heteromultimeric polypeptides |
| 09/06/1996 | WO1996027010A1 Murine/human chimeric monoclonal antibody or a fragment thereof specific for the egf receptor |
| 09/06/1996 | WO1996027009A1 Human amine transporter |
| 09/06/1996 | WO1996027004A1 An immortalized mammal hybridoma fusion partner |
| 09/06/1996 | WO1996026964A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
| 09/06/1996 | WO1996026963A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 09/06/1996 | WO1996026954A1 FsF-1 AND THE EARLY DETECTION OF FIBROSIS |
| 09/06/1996 | WO1996026953A1 FsF-1 AND THE EARLY DETECTION OF FIBROSIS |
| 09/06/1996 | WO1996026736A1 Vascular endothelial growth factor-b |
| 09/06/1996 | WO1996026735A1 Method for stimulating an immune response |
| 09/06/1996 | WO1996021000A3 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 09/06/1996 | WO1996020688A3 Triggered pore-forming agents |
| 09/06/1996 | WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 09/06/1996 | WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/06/1996 | WO1996019965A3 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 09/06/1996 | WO1996017934A3 Cloning and recombinant production of crf receptor(s) |
| 09/06/1996 | CA2217186A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 09/06/1996 | CA2213669A1 Transgenic animals as model of psoriasis |
| 09/04/1996 | EP0729976A1 Reconstituted human antibody against human medulloblastomatous cell |
| 09/04/1996 | EP0729517A1 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
| 09/04/1996 | EP0729300A1 Novel fas protein and methods of use thereof |
| 09/04/1996 | EP0667896A4 Direct selection of cells by secretion product. |
| 09/04/1996 | EP0491014B1 Sm-D ANTIGEN PEPTIDES AND THEIR USE, IN PARTICULAR, FOR THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS |
| 09/04/1996 | EP0458878B1 Monoclonal antibody to novel antigen associated with human tumors |
| 09/04/1996 | CN1130406A Monoclonal antibody that recognizes interstitial cell surface antigen |
| 09/04/1996 | CN1130405A Monoclonal antibody that induces apoptosis |
| 09/04/1996 | CN1130193A Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor (EGF-R) and its diagnosis and therapeutical use |
| 09/03/1996 | US5552875 Paper delivery apparatus for a duplex printer |
| 09/03/1996 | US5552537 IgE isoforms and methods of use |
| 09/03/1996 | US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III) |
| 09/03/1996 | US5552530 Antibodies that specifically bind to and inhibit human synovial phospholipase A2 type A |
| 09/03/1996 | US5552526 Genetic engineering and dna sequences |
| 09/03/1996 | US5552381 Recombinantly produced human membrane cofactor protein (MCP) pharmaceutical composition, and method of inhibiting complement activity |
| 09/03/1996 | US5552304 Polypeptide plasmid vectors for dna sequences |
| 09/03/1996 | US5552295 Monoclonal antibodies to bovine haptoglobin and methods for detecting serum haptoglobin levels |
| 09/03/1996 | US5552293 Tumor antigen specific antibody |
| 09/03/1996 | US5552291 Contacting a sample with monoclonal antibodies secreted by hybridoma cells and detection binding to adenocarcinomas |
| 09/03/1996 | US5552287 Monoclonal antibody specific for antigens in mouse inbred strains |
| 09/03/1996 | US5552286 Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 09/03/1996 | US5552284 Detection of interleukin-8 receptors by nudeic acid hybridization |
| 09/03/1996 | US5552281 Human osteoclast-specific and -related genes |
| 09/03/1996 | US5552146 Methods and compositions relating to useful antigens of Moraxella catarrhalis |
| 09/03/1996 | US5552086 Gold and silver on polystyrene, useful for raman spectroscopy and flow cytometry, interlayer of aminodextran |
| 09/03/1996 | CA1338570C Endowing cells with antibody specificity |
| 08/29/1996 | WO1996026442A1 Early detection of prostate cancer (cap) by determining a ratio involving prostate specific antigen (psa) and human glandular kallikrein (hgk-1) concentrations |
| 08/29/1996 | WO1996026288A1 A method for the isolation and purification of lipid cell-wall components |
| 08/29/1996 | WO1996026275A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 08/29/1996 | WO1996026274A1 Antagonists of interleukin-15 |
| 08/29/1996 | WO1996026272A1 Prostate-specific membrane antigen and uses thereof |
| 08/29/1996 | WO1996026217A1 Novel protein and methods for the production of the same |
| 08/29/1996 | WO1996026214A1 Isolated nonapeptides presented by hla molecules, and uses thereof |